PEOPLE - Beckman Coulter makes appointment:
This article was originally published in Clinica
US clinical diagnostics and biomedical research firm Beckman Coulter (Fullerton, California) has named CEO and company president Scott Garrett as chairman of the board, effective from April 24 2008. To take effect on the same date, non-executive chair Betty Woods will become lead independent director.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.